Pharma: Other News To Note
Ferring Pharmaceuticals SA, of Saint Prex, Switzerland, said it received confirmation from European health authorities that its marketing authorization application for its controlled release, removable misoprostol vaginal delivery system (MVDS) has been accepted for review under the decentralized procedure.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.